Polymers for Extrusion-Based 3D Printing of Pharmaceuticals: A Holistic Materials–Process Perspective
Open accessThe DOI matches its Crossref record; 172 of the 176 references it cites were found in a registry or an index.
Abstract
Three dimensional (3D) printing as an advanced manufacturing technology is progressing to be established in the pharmaceutical industry to overcome the traditional manufacturing regime of 'one size fits for all'. Using 3D printing, it is possible to design and develop complex dosage forms that can be suitable for tuning drug release. Polymers are the key materials that are necessary for 3D printing. Among all 3D printing processes, extrusion-based (both fused deposition modeling (FDM) and pressure-assisted microsyringe (PAM)) 3D printing is well researched for pharmaceutical manufacturing. It is important to understand which polymers are suitable for extrusion-based 3D printing of pharmaceuticals and how their properties, as well as the behavior of polymer–active pharmaceutical ingredient (API) combinations, impact the printing process. Especially, understanding the rheology of the polymer and API–polymer mixtures is necessary for successful 3D printing of dosage forms or printed structures. This review has summarized a holistic materials–process perspective for polymers on extrusion-based 3D printing. The main focus herein will be both FDM and PAM 3D printing processes. It elaborates the discussion on the comparison of 3D printing with the traditional direct compression process, the necessity of rheology, and the characterization techniques required for the printed structure, drug, and excipients. The current technological challenges, regulatory aspects, and the direction toward which the technology is moving, especially for personalized pharmaceuticals and multi-drug printing, are also briefly discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






![Figure 7 Viscosity ratio (η/ηo) of acetaminophen (APAP) in poly (ethylene oxide) (PEO) at different temperatures to determine the solubility of the drug. Reprinted with permission from M Yang, International Journal of Pharmaceutics, Published by Elsevier, 2011 [123].](https://figures.cochat.ai/paper-figures/5b0f2d6634994ae79cc2c2cbcb3eb075/polymers-for-extrusion-based-3d-printing-of-pharmaceuticals-a-holistic-figure-7.jpg)
![Figure 8 The rheological characterization of the blends of different polymers [Affinisol 15LV (Aff15), Kollidon SR (KollSR), Eudragit EPO (EPO), hydroxypropyl cellulose (HPC)]. Constituent effect visualized with frequency sweep at the maximum processing temperature (200 °C). Reprinted with permission from K Ilyés, European Journal of Pharmaceutical Sciences, Published by Elsevier, 2019 [136].](https://figures.cochat.ai/paper-figures/b1ca4ae8602d4e64bbc6cbb3bfa0f28d/polymers-for-extrusion-based-3d-printing-of-pharmaceuticals-a-holistic-figure-8.jpg)

![Figure 10 (a) Design of tablets, (b) the relationship between the target and achieved prednisolone dose, and (c) PVA based FDM 3D printed tablets having different dose strengths [56].](https://figures.cochat.ai/paper-figures/76d1606acd2449ce8e030af1e4501a72/polymers-for-extrusion-based-3d-printing-of-pharmaceuticals-a-holistic-figure-10.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“3D printing enables the fabrication of complex three-dimensional structures via computer-aided design, allows precise control over scaffold porosity, pore size, and microstructure, and facilitates accurate modulation of mechanical strength, and creates microstructures with graded porosity within a single scaffold [88–90].”
From Application of PLCL as a biodegradable polymer in biomedical engineering (2026) · cites this paper as [88]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Polymers for 3D Printing and Customized Additive Manufacturing
Ligon, S. C., Liska, R., Stampfl, J., Gurr, M., & Mülhaupt, R. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00074 · Cited by 3,741
Farah, S., Anderson, D. G., & Langer, R. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.06.012 · Cited by 3,443
Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC)
Siepmann, J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00112-0 · Cited by 2,613
Biomedical applications of biodegradable polymers
Ulery, B. D., Nair, L. S., & Laurencin, C. T. (2011) · Journal of Polymer Science Part B: Polymer Physics · doi:10.1002/polb.22259 · Cited by 2,206
Correlation of dynamic and steady flow viscosities
Cox, W. P., & Merz, E. H. (1958) · Journal of Polymer Science · doi:10.1002/pol.1958.1202811812 · Cited by 2,092
Personalized medicine: Time for one-person trials
Schork, N. J. (2015) · Nature · doi:10.1038/520609a · Cited by 1,223
Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC)
Siepmann, J., & Peppas, N. A. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.028 · Cited by 1,021
Awaja, F., Gilbert, M., Kelly, G., Fox, B., & Pigram, P. J. (2009) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2009.04.007 · Cited by 928
Three-Dimensional Printing: Rapid Tooling and Prototypes Directly from a CAD Model
Sachs, E., Cima, M., & Cornie, J. (1990) · CIRP Annals · doi:10.1016/s0007-8506(07)61035-x · Cited by 871
A new chapter in pharmaceutical manufacturing: 3D-printed drug products
Norman, J., Madurawe, R. D., Moore, C. M. V., Khan, M. A., & Khairuzzaman, A. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.03.001 · Cited by 810
Research works printed but not linked: 3
- 107. Hardung H., Djuric D., Ali S. Combining HME & solubilization: Soluplus®—The solid solution. Drug Deliv. Technol. 2010;10:20–27.
- 134. Aho J., Genina N., Edinger M., Botker J.P., Baldursdottir S., Rantanen J. Drug-loaded poly (ε-caprolactone) for 3D printing of personalized medicine: A rheological study; Proceedings of the 25th Nordic Rheology Conference; Helsinki, Finland. 30 May–1 June 2016; pp. 97–100.
- 164. Campbell R. Pharma to table: 3-D printing and the regulatory future of home remedies. Conn. L. Rev. CONNtemplations. 2017;49:1.
Cited by
Items 101–200 of 355
Additive manufacturing in nano drug delivery systems
Rahman, M. H., Liza, N. Y., Hossain, K. R., Kalambhe, D. R., Shyeed, M. A., & Noor, D. H. (2024) · Pharmaceutical Science Advances · doi:10.1016/j.pscia.2024.100036 · Cited by 41
“Moreover, it is critical to de fi ne the critical quality attributes of the drug substance early in drug development by understanding the properties of the active pharmaceutical molecule (API) [6,7].”
Preformulation Studies to Guide the Production of Medicines by Fused Deposition Modeling 3D Printing
Pinho, L. A. G., Lima, A. L., Barreto, L. C. L. D. S., Gratieri, T., Gelfuso, G. M., Marreto, R. N., & Cunha‐Filho, M. (2021) · AAPS PharmSciTech · doi:10.1208/s12249-021-02114-7 · Cited by 32
“In fact, the rheological behavior of the formulation plays a central role in both processes because it determines the matrix viscosity during processing, as well as drug distribution and the polymer’s printability (4, 10).”
BackgroundInfluentialHenry, S., Wever, L. D., Vanhoorne, V., Beer, T. D., & Vervaet, C. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13122068 · Cited by 33
Development of mAb-loaded 3D-printed (FDM) implantable devices based on PLGA
Carlier, E., Marquette, S., Peerboom, C., Amighi, K., & Goole, J. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120337 · Cited by 32
A 3D-Printed Polymer–Lipid-Hybrid Tablet towards the Development of Bespoke SMEDDS Formulations
Barber, B. W., Dumont, C., Caisse, P., Simon, G. P., & Boyd, B. J. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13122107 · Cited by 34
“Recently, FDM has gained greater interest with the development of new polymers that may be coextruded, with a drug, at lower temperatures to avoid thermal degradation during the extrusion process [21,22].”
BackgroundInvestigation of Patient-Centric 3D-Printed Orodispersible Films Containing Amorphous Aripiprazole
Lee, J., Park, C., Song, I.-O., Lee, B., Kang, C.-Y., & Park, J.-B. (2022) · Pharmaceuticals · doi:10.3390/ph15070895 · Cited by 31
“These properties can design immediate-release solid dosage forms [40].”
BackgroundSuitability Analysis for Extrusion-Based Additive Manufacturing Process
Altıparmak, S. C., & Daminabo, S. I. C. (2024) · Additive Manufacturing Frontiers · doi:10.1016/j.amf.2023.200106 · Cited by 37
3D Printing of Hydrogel Polysaccharides for Biomedical Applications: A Review
Aghajani, M., Garshasbi, H. R., Naghib, S. M., & Mozafari, M. R. (2025) · Biomedicines · doi:10.3390/biomedicines13030731 · Cited by 41
Falcone, G., Real, J. P., Palma, S. D., Aquino, R. P., Gaudio, P. D., Garofalo, E., & Russo, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031280 · Cited by 38
Rheological and mechanical assessment for formulating hybrid feedstock to be used in MIM & FFF
Naranjo, J. A., Berges, C., Campana, R., & Herranz, G. (2023) · Results in Engineering · doi:10.1016/j.rineng.2023.101258 · Cited by 33
Cotabarren, I. M., & Gallo, L. (2020) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2020.1791166 · Cited by 33
Curti, C., Kirby, D. J., & Russell, C. A. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13050616 · Cited by 32
“However, pharmaceutical applications of VP technologies still account for the smaller share and remain underdeveloped [7,31].”
BackgroundMora-Castaño, G., Millán, M., Linares, V., & Caraballo, I. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14040871 · Cited by 29
“In addition to the polymers and the drug concerned, it is common to use auxiliary excipients such as plasticizer, lubricants, antioxidants, and fillers [1,6,8].”
BackgroundInfluentialRecent Advancements in Pharmaceutical 3D Printing Industry
Kulkarni, V. R., Saha, T., Giri, B. R., Lu, A., Das, S. C., & Maniruzzaman, M. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.106072 · Cited by 37
Shams, H., Basit, K., Khan, M., Saleem, S., & Mansoor, A. (2021) · Additive manufacturing · doi:10.1016/j.addma.2020.101777 · Cited by 30
Tagami, T., Morimura, C., & Ozeki, T. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120721 · Cited by 29
Kukkonen, J., Ervasti, T., & Laitinen, R. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103843 · Cited by 28
Rising role of 3D-printing in delivery of therapeutics for infectious disease
Kyser, A. J., Fotouh, B., Mahmoud, M. Y., & Frieboes, H. B. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.12.051 · Cited by 29
Turac, I.-R., Porfire, A. S., Iurian, S., Crișan, A. G., Casian, T., Iovanov, R., & Tomuță, I. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16060790 · Cited by 26
“Both are extrusion-based technologies, relying on the layer-by-layer deposition of molten mixtures (in FDM) or semi-solid materials (in PAM) on a Build Platform to obtain the desired structure, which is defined using a specialized software [8,10].”
BackgroundMethodHot-Melt 3D Extrusion for the Fabrication of Customizable Modified-Release Solid Dosage Forms
Lee, J., Song, C., Noh, I., Song, S., & Rhee, Y.-S. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12080738 · Cited by 26
“Nevertheless, the pre-process step required for preparing filament remains as a limitation [19,20].”
BackgroundPharmaceutical Applications of Pectin
Akin-Ajani, O. D., & Okunlola, A. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.100152 · Cited by 37
Hot Melt Extrusion and its Application in 3D Printing of Pharmaceuticals
Deshkar, S. S., Rathi, M., Zambad, S., & Gandhi, K. (2020) · Current Drug Delivery · doi:10.2174/1567201817999201110193655 · Cited by 25
3D printing for controlled release Pharmaceuticals: Current trends and future directions
Deng, M., Wu, S., & Ning, M. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.125089 · Cited by 24
Revolutionizing Patient Care: 3D Printing for Customized Medical Devices and Therapeutics
Borthakur, P. P., Das, A., Sahariah, J. J., Pramanik, P., Baruah, E., & Pathak, K. (2025) · Biomedical Materials & Devices · doi:10.1007/s44174-025-00324-2 · Cited by 52
“In emergencies or disaster zones, it can minimize medication waste and maximize efficiency by producing drugs only when needed [154–157].”
Innovative applications of 3D printing in personalized medicine and complex drug delivery systems
Kapoor, D. U., Pareek, A., Uniyal, P., Prajapati, B. G., Thanawuth, K., & Sriamornsak, P. (2025) · iScience · doi:10.1016/j.isci.2025.113505 · Cited by 40
“8,17 Considering these benefits, 3D printing presents problems compared to conventional pharmaceutical manufacturing procedures, especially for large-scale production.”
Thermoplastic Cellulose-Based Compound for Additive Manufacturing
Immonen, K., Willberg‐Keyriläinen, P., Ropponen, J., Nurmela, A., Metsä-Kortelainen, S., Kaukoniemi, O.-V., & Kangas, H. (2021) · Molecules · doi:10.3390/molecules26061701 · Cited by 24
“In medical applications extrusion printing of thermoplastic cellulose-derivatives for example ethyl cellulose, is a known technology [32,33].”
BackgroundMain 3D Manufacturing Techniques for Customized Bone Substitutes. A Systematic Review
Montero, J., Becerro, A., Pardal-Peláez, B., Quispe‐López, N., Blanco, J. F., & Gómez‐Polo, C. (2021) · Materials · doi:10.3390/ma14102524 · Cited by 24
Dubashynskaya, N. V., & Skorik, Y. А. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232112980 · Cited by 26
Roche, A., Sanchez‐Ballester, N. M., Aubert, A., Rossi, J., Bégu, S., & Soulairol, I. (2023) · AAPS PharmSciTech · doi:10.1208/s12249-023-02582-z · Cited by 24
Raziyan, M. S., Palevičius, A., Perkowski, D. M., Urbaite, S., & Janušas, G. (2024) · Journal of Composites Science · doi:10.3390/jcs8060226 · Cited by 29
“Several PLA blends have been investigated for use in biomedical applications such as drug delivery, implants, sutures and tissue engineering [10].”
BackgroundHolkunde, A., Karnik, I., Uttreja, P., Narala, N., Wang, H., Elkanayati, R. M., Vemula, S. K., & Repka, M. A. (2025) · Pharmaceutical Research · doi:10.1007/s11095-024-03813-z · Cited by 25
3D Printing of Solvent-Free Supramolecular Polymers
Rupp, H., & Binder, W. H. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2021.771974 · Cited by 24
“will prevent nozzle blockage or polymer dripping (Azad et al., 2020).”
BackgroundVarghese, R., Salvi, S., Sood, P., Karsiya, J., & Kumar, D. (2022) · Annals of 3D Printed Medicine · doi:10.1016/j.stlm.2022.100081 · Cited by 31
Mandati, P., Dumpa, N., Alzahrani, A. G., Nyavanandi, D., Narala, S., Wang, H., Bandari, S., Repka, M. A., Tiwari, S., & Langley, N. (2022) · AAPS PharmSciTech · doi:10.1208/s12249-022-02470-y · Cited by 23
Three-Dimensional Printing for Oral Pharmaceutical Dosage Forms
Kim, J. H., Kim, K., & Jin, H. (2022) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-022-00561-3 · Cited by 22
“Polymers such as PLA, PCL, and Eudragit® RL show a slow degradation time due to poor water solubility and stability, which leads to a long life-time in vivo (Azad et al. 2020).”
BackgroundCustomized 3D printed multi-drug systems: an effective and efficient approach to polypharmacy
Mazarura, K. R., Kumar, P., & Choonara, Y. E. (2022) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2022.2121816 · Cited by 22
“tablets as it dissolves more readily in hydrochloric acid [54].”
BackgroundPharmaceutical 3D-printing of nanoemulsified eucalypt extracts and their antimicrobial activity
Коshovyi, O., Heinämäki, J., Raal, A., Laidmäe, I., Topelius, N. S., Komisarenko, M. A., & Komissarenko, A. (2023) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2023.106487 · Cited by 22
Enhancing Mechanical Properties of 3D-Printed PLAs via Optimization Process and Statistical Modeling
shahrjerdi, A., Karamimoghadam, M., & Bodaghi, M. (2023) · Journal of Composites Science · doi:10.3390/jcs7040151 · Cited by 25
Clinical implementation of a paediatric 3D-printed combination of Sulfamethoxazole and Trimethoprim
Stoops, M., Do, B., Ramos, S., Tan, B. X., Chua, N. Y. S., Mazet, R., Guiblin, N., Michelet, A., Flynn, S., Abbou, S. D., et al. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125581 · Cited by 21
“This property is crucial for maintaining print fidelity and is consistent with studies showing that the quality of 3D printing depends on the ink ’ s flow behaviour, viscosity, and thermal properties (Azad et al., 2020; Wedamulla et al., 2023; Chen et al., 2019).”
Current and Prospective Applications of 3D Printing in Cosmetics: A Literature Review
Jiao, Y., Stevic, M., Buanz, A. B. M., Uddin, J., & Tamburić, S. (2022) · Cosmetics · doi:10.3390/cosmetics9060115 · Cited by 24
“The healthcare and medical industry has already benefited from 3DP with versatile applications, from 3D printed pharmaceuticals in solid and semisolid forms [5,6], to those with complex release profiles [7].”
BackgroundArchana, M., Rubini, D., Dharshini, K. P., Hari, B. N. V., Senthilganesh, J., Ramyadevi, D., Gonciarz, W., Domańska, A., Brzeziński, M., & Nithyanand, P. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.126029 · Cited by 27
Gutíerrez, C. L. P., Cottone, F., Pagano, C., Michele, A. D., Puglia, D., Luzi, F., Dominici, F., Sinisi, R., Ricci, M., Viseras, C., et al. (2023) · Polymers · doi:10.3390/polym15183792 · Cited by 23
“Generally, for PAM printing, it is preferable to use semisolid formulations having shear-thinning behavior, as this property is responsible for the ability to be pushed through a nozzle [3,32].”
MethodRole of rheology in formulation and process design of hot melt extruded amorphous solid dispersions
Badruddoza, A. Z. M., Moseson, D. E., Lee, H.-G., Esteghamatian, A., & Thipsay, P. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124651 · Cited by 21
Self-citationPaliperidone palmitate as model of heat-sensitive drug for long-acting 3D printing application
Manini, G., Benali, S., Mathew, A., Napolitano, S., Raquez, J., & Goole, J. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.121662 · Cited by 20
“The first drug-loaded filaments were obtained by soaking a commercial filament made of PVA in an ethanolic solution made of drug (Goyanes et al., 2014).”
BackgroundMethodInfluentialPanraksa, P., Rachtanapun, P., Thipchai, P., Lesniewska, É., Brachais, C., Debeaufort, F., Chambin, O., & Jantrawut, P. (2023) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2023.03.006 · Cited by 20
In Vitro Tests of FDM 3D-Printed Diclofenac Sodium-Containing Implants
Arany, P., Papp, I., Zichar, M., Csontos, M., Elek, J., Regdon, G., Budai, I., Béres, M., Gesztelyi, R., Fehér, P. S., et al. (2020) · Molecules · doi:10.3390/molecules25245889 · Cited by 23
“One of the most studied 3D printing techniques is fused deposition modeling (FDM) or fused filament fabrication (FFF) [8], which is a process that places a molten polymer layer-by-layer on top of an already printed layer to build a desired object [9].”
BackgroundPectins - The New-Old Polysaccharides
Masuelli, M. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.94714 · Cited by 21
A Review on the Application of 3D Printing Technology in Pavement Maintenance
Gong, F., Cheng, X., Wang, Q., Chen, Y., You, Z., & Liu, Y. (2023) · Sustainability · doi:10.3390/su15076237 · Cited by 19
Remaggi, G., Bottari, B., Bancalari, E., Catanzano, O., Neviani, E., & Elviri, L. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.124454 · Cited by 21
Vlad, R.-A., Pintea, A., Coaicea, M., Antonoaea, P., RÉDAI, E. M., Todoran, N., & Ciurba, A. (2023) · Polymers · doi:10.3390/polym15092034 · Cited by 19
“HPMC is a swellable, water-soluble polymer that enhances the sustained-release proprieties of active ingredients in pharmaceuticals and is used for immediate-release dosage forms [9].”
BackgroundBergonzi, C., Bianchera, A., Remaggi, G., Ossiprandi, M. C., Zimetti, F., Marchi, C., Bernini, F., Bettini, R., & Elviri, L. (2021) · Applied Sciences · doi:10.3390/app11167253 · Cited by 22
“The use of threedimensional printing provides the chance to design more complex devices in terms of geometry and control of drug release towards the target of tailored personalized medicine with respect to traditional manufacturing processes [29,30].”
BackgroundDesign of a Pharmaceutical 3D Printer Using Quality-by-Design Approach
Lafeber, I., de Boer, T. W. J., van Unen, W. H., Ouwerkerk, N., Guchelaar, H., & Schimmel, K. J. M. (2024) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-024-09889-9 · Cited by 18
“A smaller nozzle will have a greater back pressure on the feedstock, changing the viscosity and elastic recovery of the feedstock as it is likely and preferably a non-Newtonian substance [12].”
Sierra-Vega, N. O., Ashraf, M., O’Connor, T. F., Kopcha, M., Prima, M. D., Coburn, J., & Zidan, A. S. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125415 · Cited by 20
Personalised urethra pessaries prepared by material extrusion-based additive manufacturing
Spoerk, M., Arbeiter, F. J., Koutsamanis, I., Cajner, H., Katschnig, M., & Eder, R. J.-P. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.121112 · Cited by 18
Hartzke, D., Pössl, A., Schlupp, P., & Runkel, F. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14102103 · Cited by 18
“Additionally, low-Mw HPC grades have been shown to produce chemically stable formulations with poorly and highly water-soluble APIs after being hot-melt mixed [26], making HPC a versatile excipient, suitable for HME and the 3D printing of different drug delivery systems.”
BackgroundMethodInfluentialKumari, J., Pandey, S., Jangde, K. K., Kumar, P. V., & Mishra, D. K. (2024) · Bioprinting · doi:10.1016/j.bprint.2024.e00367 · Cited by 22
Lin, Y., Deng, W., Rui, Y., Liu, Y., Lu, G., & Liu, J. (2022) · Journal of Applied Polymer Science · doi:10.1002/app.52629 · Cited by 18
Salama, A. H. (2025) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-025-00866-8 · Cited by 27
“Fused-deposition modeling printers are rapid and cheap in printing, this merit aided in their widespread use; however, they demonstrate a limited use with thermosensitive drugs owing to the exposure to high temperature [46].”
Engineering 3D-Printed Advanced Healthcare Materials for Periprosthetic Joint Infections
Yuste, I., Luciano, F. C., Anaya, B. J., Sanz-Ruíz, P., Ribed, A., González‐Burgos, E., & Serrano, D. R. (2023) · Antibiotics · doi:10.3390/antibiotics12081229 · Cited by 20
“PVA 180–228 ◦C Suitable for inkjet printing and FDM Good biodegradability and minimal adverse effects Suitable for immediate and controlled release [6,78]”
BackgroundКоshovyi, O., Heinämäki, J., Laidmäe, I., Topelius, N. S., Grytsyk, A. R., & Raal, A. (2023) · Annals of 3D Printed Medicine · doi:10.1016/j.stlm.2023.100123 · Cited by 20
Khiari, Z. (2024) · Marine Drugs · doi:10.3390/md22030134 · Cited by 21
“…to the desired location, low stability, may require further chemical modification [25–27] E x t r u s i o n Pneumatic-, Screw-and/or Piston-Driven 100 µ m [30] 40–80% [30,31] Simple and affordable, good mechanical resistance, possibility to use multiple materials simultaneously [25–27,32,33]”
3D printing of bioactive materials for drug delivery applications
Nasiri, G., Ahmadi, S., Shahbazi, M., Nosrati‐Siahmazgi, V., Fatahi, Y., Dinarvand, R., Rabiee, M., Haftlang, F., Kim, H. S., & Rabiee, N. (2022) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2022.2112944 · Cited by 17
Extrusion bioprinting: meeting the promise of human tissue biofabrication?
Holland, I. (2025) · Progress in Biomedical Engineering · doi:10.1088/2516-1091/adb254 · Cited by 26
“Printability windows also impact other modalities such as polymer [185, 186] and concrete extrusion [187], but without the difficulty of including living cells.”
A Recent Review On 3D-Printing: Scope and Challenges with Special Focus on Pharmaceutical Field
Singh, S. K., Kumar, M., Doolaanea, A. A., & Mandal, U. K. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612828666220623091629 · Cited by 16
Zhang, Y., Peng, W., Cao, Y., Wang, W., Teng, D., Huang, Y., & Fan, G. (2023) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2023.131603 · Cited by 17
A Bibliometric Analysis of 3D Printing in Personalized Medicine Research from 2012 to 2022
Xue, A.-L., Li, W., Tian, W., Zheng, M.-Y., Shen, L., & Hong, Y. (2023) · Pharmaceuticals · doi:10.3390/ph16111521 · Cited by 19
Adib, A. Z., Pratama, J., Badranaya, M. I., Mahardika, M., Suyitno, Salim, U. A., & Arifvianto, B. (2024) · The International Journal of Advanced Manufacturing Technology · doi:10.1007/s00170-024-13608-6 · Cited by 22
“Considering such benefits, AM has therefore been utilized for many applications, starting as a means for aiding the fabrication of prosthetics [6, 7] and biomedical implants [8, 9] up to customizing drug dosages in pharmaceuticals [10, 11].”
Коshovyi, O., Sepp, J., Jakštas, V., Žvikas, V., Kireyev, I. V., Karpun, Y., Odyntsova, V. M., Heinämäki, J., & Raal, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158292 · Cited by 22
PLGA – THE SMART POLYMER FOR DRUG DELIVERY
Surya, N., & Bhattacharyya, S. (2021) · Pharmacy & Pharmacology · doi:10.19163/2307-9266-2021-9-5-334-345 · Cited by 20
Salunkhe, S. S., Murali, A. P., Moneam, H. M. A., Naranje, V. G., & Shanmugam, R. (2022) · Polymer-Plastics Technology and Materials · doi:10.1080/25740881.2022.2133612 · Cited by 15
“However, poor mechanical strength and durability restrict their functionality in wide applications.([70]) 3D printing of polymers with various fibrous, particulate, or nanoscale reinforcements to form composites can certainly solve these problems.”
BackgroundChoudary, R., Saini, N., Chopra, D. S., Singh, D., & Singh, N. (2023) · Journal of materials research/Pratt's guide to venture capital sources · doi:10.1557/s43578-023-01078-7 · Cited by 21
Kreft, K., Lavrič, Z., Centa, U. G., Mihelčič, M., Perše, L. S., & Dreu, R. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.123719 · Cited by 15
Wang, Y., Wang, X., Xie, M., Zhou, Z., & Xu, H. (2022) · Polymer Composites · doi:10.1002/pc.26903 · Cited by 15
Goto, E., Tagami, T., Ogawa, K., & Ozeki, T. (2023) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b23-00443 · Cited by 16
Porwal, S., Malviya, R., Sridhar, S. B., Meenakshi, D. U., Wadhwa, T., Shareef, J., & Warsi, M. H. (2025) · Annals of 3D Printed Medicine · doi:10.1016/j.stlm.2025.100209 · Cited by 14
Sagris, D., David, C., Petousis, M., Nasikas, N. K., Mountakis, N., Spyridaki, M., & Vidakis, N. (2025) · ACS Omega · doi:10.1021/acsomega.5c07437 · Cited by 13
Pflieger, T., Venkatesh, R., Dachtler, M., Eggenreich, K., Laufer, S., & Lunter, D. J. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14112488 · Cited by 13
“Further optimization of the nozzle throughput can be addressed in multiple ways by adjusting print parameters such as the printing temperature, print speed, screw speed, or layer height [26,39,40].”
BackgroundMethodInfluential3D printing tablets for high-precision dose titration of caffeine
Krueger, L., Cao, Y., Zheng, Z., Ward, J., Miles, J. A., & Popat, A. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.123132 · Cited by 15
Elumalai, A., Nayak, Y., Ganapathy, A. K., Chen, D., Tappa, K. K., Jammalamadaka, U. M., Bishop, G. L., & Ballard, D. H. (2023) · Polymers · doi:10.3390/polym15214306 · Cited by 17
“Over 80% of published data for 3DP applications utilized extrusion-based printers [8].”
BackgroundPedrini, F., Gomes, R. C., Moraes, A. D. S., Antunes, B. S. L., Motta, A. C., Dávila, J. L., Hausen, M. D. A., Komatsu, D., & Duek, E. A. D. R. (2023) · Polymer · doi:10.1016/j.polymer.2023.126585 · Cited by 13
Pflieger, T., Venkatesh, R., Dachtler, M., Cooke, K., Laufer, S., & Lunter, D. J. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124207 · Cited by 14
Yasin, H. K. A., Al-Tabakha, M. M., & Chan, S. Y. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16101285 · Cited by 19
“The term FDM, “Fused Deposition Modeling”, is based upon extrusion, where it relies on building multiple layers of melted material [10].”
BackgroundMichael, B., Jayaprakash, N., Munivel, N., & Jaisankar, D. (2025) · Medicine in Drug Discovery · doi:10.1016/j.medidd.2025.100242 · Cited by 12
Application Analysis of 3D Printing Technology in Design Field: Taking Shoe Design as an Example
Gong, T., & Kang, L.-P. (2021) · Scientific Programming · doi:10.1155/2021/5662460 · Cited by 12
“,e process from the human foot to the shoe last belongs to a kind of reverse engineering; that is, the human foot is used as the design object, and the last is designed and manufactured in turn to obtain the shoe last [4].”
BackgroundRetractedRecent progress in orodispersible films‐mediated therapeutic applications: A review
Tian, Y., Lin, J., Jing, H., Wang, Q., Wu, Z., & Duan, Y. (2023) · MedComm – Biomaterials and Applications · doi:10.1002/mba2.34 · Cited by 12
Park, C., Renuka, V., Lee, B., de la Peña, I., & Park, J.-B. (2024) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-024-00684-9 · Cited by 12
“In particular, polymers for 3D-printing technology utilize HME technology to improve the preparation of solid dosage forms, such as films, strips, and implants, further expanding the versatility of this technology (Azad et al. 2020).”
Patel, G., & Minko, T. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.125124 · Cited by 12
Recent Advances in 3D Printing for Parenteral Applications
Ivone, R., Yang, Y., & Shen, J. (2021) · The AAPS Journal · doi:10.1208/s12248-021-00610-z · Cited by 14
“Common filament materials used include biocompatible thermoplastic polymers such as polyvinyl alcohol (PVA), poly(lactic acid) (PLA), and polyvinylpyrrolidone [10].”
BackgroundLong-acting implantable dosage forms containing paliperidone palmitate obtained by 3D printing
Manini, G., Deldime, M. R., Benali, S., Raquez, J., & Goole, J. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120702 · Cited by 14
“As mentioned by Azad et al , between 2015 and 2019, the extrusion-based printing represented more than 80% of published articles on 3D printing (Azad et al., 2020).”
BackgroundAhmed, A. A., Schimmel, K. J. M., Tubić-Grozdanis, M., Tuleu, C., Smith, J., Soulairol, I., Dadkhah, A., Paulson, M., Lechanteur, A., Carrez, L., et al. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.126321 · Cited by 12
Enhancing antioxidant delivery through 3D printing: a pathway to advanced therapeutic strategies
Alogla, A. F. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1256361 · Cited by 12
A Review on Physicochemical Properties of Polymers Used as Filaments in 3D-Printed Tablets
Doolaanea, A., Latif, N., Singh, S. K., Kumar, M., Safa'at, M. F., Alfatama, M., Edros, R. Z., & Bhatia, A. (2023) · AAPS PharmSciTech · doi:10.1208/s12249-023-02570-3 · Cited by 11
“However, given that the uses have expanded to include surgical sutures and implants, it is necessary to study polymer materials with excellent physical, chemical, biological, and degradation-related characteristics [17, 19].”
BackgroundJoule Heating Activation of 4D Printed Conductive PLA Actuators
Lee, Y. C., Alshebly, Y. S., & Marwan Nafea, M. (2022) · IEEE International Conference on Automatic Control and Intelligent Systems (I2CACIS) · doi:10.1109/i2cacis54679.2022.9815495 · Cited by 15
“It functions by extruding the desired materials, which are in melted form, through a nozzle over a movable platform with a pre-set path [11], [12].”
BackgroundGao, P., Muller, S. E., Chun, J., Zhong, L., & Kennedy, Z. C. (2023) · Polymer · doi:10.1016/j.polymer.2023.125722 · Cited by 14
Коshovyi, O., Hrytsyk, Y., Perekhoda, L. O., Suleiman, М., Jakštas, V., Žvikas, V., Grytsyk, L., Yurchyshyn, O., Heinämäki, J., & Raal, A. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17040407 · Cited by 10
“A promising strategy here could be the use of pharmaceutical 3D printing [21,22] for preparing novel oral dosage forms to improve the efficacy and patient compliance of plant-origin medicines.”
Impression 2D-3D dans les pharmacies hospitalières : quels rôles et quels challenges ?
Annereau, M., Toussaint, B., Wojcicki, A. D., Dufaÿ, S., Diaz-Salmeron, R., & Boudy, V. (2021) · Annales Pharmaceutiques Françaises · doi:10.1016/j.pharma.2021.01.002 · Cited by 12
Chaiwarit, T., Aodsab, N., Promyos, P., Panraksa, P., Udomsom, S., & Jantrawut, P. (2022) · Scientia Pharmaceutica · doi:10.3390/scipharm90040068 · Cited by 10
3D printed multilayer dielectric elastomer actuators
Su, S., He, T., & Yang, H. Y. (2023) · Smart Materials and Structures · doi:10.1088/1361-665x/acb677 · Cited by 10
“The shear viscosity of the ink determines its flow resistance; the viscosity of the ink is too high, making it difficult to extrude [19], whereas a lower viscosity affects the quality of ink deposition [20].”
Amin, O. M., Qady, H. N. E., & El-Fattah, M. A. A. (2023) · AAPS PharmSciTech · doi:10.1208/s12249-023-02578-9 · Cited by 10
Fabrication and evaluation of PLA/MgAl2O4 scaffolds manufactured through 3D printing method
Ghodrati, M., Rafiaei, S. M., & Tayebi, L. (2023) · Journal of the mechanical behavior of biomedical materials/Journal of mechanical behavior of biomedical materials · doi:10.1016/j.jmbbm.2023.106001 · Cited by 10
Metadata
- Authors
- Azad, M. A., Olawuni, D., Kimbell, G., Badruddoza, A. Z. M., Hossain, M. S., & Sultana, T.
- Affiliations
- North Carolina Agricultural and Technical State University (US)
- Virginia Commonwealth University (US)
- City University of New York (US)
- Massachusetts College of Pharmacy and Health Sciences (US)
- Corresponding author
- Azad, Mohammad A.
- Venue
- Pharmaceutics
- Publisher
- MDPI AG
- Published
- 2020-02-03
- Volume
- 12
- Issue
- 2
- Pages
- 124
- ISSN
- 1999-4923 (ISSN-L)
- PMC
- PMC7076526
- OpenAlex
- W3003558240
- Semantic Scholar
- d0e7b174bfd4c9215a0e766bbf1923bb5c15a67d
- Cited by
- 356
- References
- 176
- Citations by year
- 2026: 38 · 2025: 44 · 2024: 48 · 2023: 73 · 2022: 66 · 2021: 57 · 2020: 28
- FWCI
- 3.89
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Pharmaceutics (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- CUNY Academic Works (City University of New York) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Physical Sciences › Engineering › Industrial and Manufacturing Engineering › Additive Manufacturing and 3D Printing Technologies
- Physical Sciences › Engineering › Building and Construction › Innovations in Concrete and Construction Materials
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Keywords
- material extrusion, pharmaceutical 3D printing, fused deposition modeling, polymer rheology, controlled drug release
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.